Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2014
ASCO 2014 – Immuno-Oncology
ASCO 2014 – Immuno-Oncology
Pidilizumab in Relapsed Metastatic Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Nivolumab and Erlotinib in EGFR-Mutation Positive Treatment-Resistant Advanced NSCLC
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Nivolumab in Chemotherapy-Naïve Advanced NSCLC
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Blinatumomab in Relapsed/Refractory Acute Lymphoblastic Leukemia
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Adoptive T-Cell Therapy for Cervical Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Pembrolizumab (MK-3745) in Metastatic Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Concurrent Treatment of Advanced Melanoma with Ipilimumab and Nivolumab
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Ipilimumab for Initial Treatment of Metastatic Uveal Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Nivolumab Combined with Ipilimumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Adjuvant Ipilimumab for Patients with High-Risk Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Navigating the Complex Landscape of Oral Cancer Medication
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma